What is the new drug for excessive sweating? Introducing Sofdra Gel
•
4 min read
Excessive sweating, or hyperhidrosis, affects an estimated 10 million people in the U.S., significantly impacting their quality of life. A new drug for excessive sweating, Sofdra (sofpironium bromide) topical gel, was approved by the U.S. Food and Drug Administration (FDA) in June 2024, marking a significant advancement in treating primary axillary hyperhidrosis (excessive underarm sweating). This prescription medication offers a new, patient-applied, at-home option for adults and children as young as nine.
